Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study.

Leon H KircikJavier Alonso-LlamazaresNeal BhatiaMichael BukhaloAlim R DevaniZoe D DraelosJanet DuBoisMelinda J GooderhamSteven E KempersEdward LainMark LeeAngela MooreDedee Frances Murrell Kim A PappDavid M PariserRodney SinclairMatthew ZirwasPatrick BurnettRobert C HighamDavid KrupaDavid R Berk

Published in: The British journal of dermatology (2023)

NCT04128007.

Keyphrases

double blind
clinical trial
physical activity
placebo controlled
study protocol
phase iii